Why the study?
Does antithrombotic therapy improve outcomes in patients undergoing endovascular therapy for acute ischemic stroke?
Does antithrombotic therapy improve outcomes in patients undergoing endovascular therapy for acute ischemic stroke?
This review summarizes the literature on periprocedural antithrombotic strategies during endovascular therapy for acute ischemic stroke, highlighting the balance between preventing embolization and avoiding hemorrhagic complications.
Optimal periprocedural antithrombotic strategy in EVT remains undefined; leaves open need for RCTs to balance embolization and hemorrhage risks.
In patients undergoing endovascular therapy for acute ischemic stroke, antithrombotic therapies are utilized to prevent distal embolization, arterial reocclusion, or catheter-related embolism. However, this must be weighed against the risk of hemorrhagic complications secondary to existing and ongoing ischemia or silent vessel perforation. In this article, we present an overview of the available literature evaluating antithrombotic therapy in patients undergoing endovascular therapy for acute ischemic stroke and discuss the emerging role of these agents.
No takes yet. Share an insight, caveat, or question.
Nahab et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: